In order to rationalize the results of in vitro enzymatic assays and cellular activity in cancer cell lines of the most potent dual CK2-α/PIM-1 inhibitors with the highest selectivity factor (SI), comprehensive in silico enzyme–substrate docking calculations were performed. Here, PIM1 is linked to cancer.